Kangchen Pharmaceutical: As of July 31, a total of 78.43 million yuan has been spent to repurchase 1.26% of its shares.

Kangchen Pharmaceutical announced that as of July 31, 2026, the company has repurchased a total of 1,998,800 shares, accounting for 1.26% of the company's total share capital, with the highest purchase price being 51.40 yuan per share and the lowest price being 28.36 yuan per share. The total amount paid is 78.4339 million yuan. The company approved the share repurchase plan on October 15, 2025, with a repurchase period of 12 months from the date of approval by the board of directors. The total repurchase funds will not be less than 50 million yuan and will not exceed 100 million yuan, intended for an employee stock ownership plan or equity incentive.